EARNINGS (LOSS) PER SHARE

6 Months Ended

Dec. 31, 2020

The following table sets forth the computation of basic and diluted net income (loss) per share:


	Three Months Ended December 31,				Six Months Ended December 31,
	2020		2019		2020		2019
Numerator:
Net income (loss) from continuing operations	$	2,151	$	1,852	$	(8,630)	$	(3,101)
Net (loss) income from discontinued operations	(11)		(2,816)		11,255		(104,884)
Net income (loss)	$	2,140	$	(964)	$	2,625	$	(107,985)

Denominator:
Basic weighted average shares outstanding	100,117		104,318		100,837		104,272
Effect of dilutive stock options, unvested restricted stock and unvested restricted share units	445		301		—		—
Diluted weighted average shares outstanding	100,562		104,619		100,837		104,272

Basic net income (loss) per common share:
Continuing operations	$	0.02	$	0.02	$	(0.09)	$	(0.03)
Discontinued operations	—		(0.03)		0.11		(1.01)
Basic net income (loss) per common share	$	0.02	$	(0.01)	$	0.02	$	(1.04)

Diluted net income (loss) per common share:
Continuing operations	$	0.02	$	0.02	$	(0.09)	$	(0.03)
Discontinued operations	—		(0.03)		0.11		(1.01)
Diluted net income (loss) per common share	$	0.02	$	(0.01)	$	0.02	$	(1.04)

Basic net income (loss) per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted share units.

Due to the net loss from continuing operations in the six months ended December 31, 2020 and 2019, all common stock equivalents such as stock options and unvested restricted stock awards have been excluded from the computation of diluted net loss per common share because the effect would have been anti-dilutive to the computations in the period.

There were 211 and 485 restricted stock awards and stock options excluded from our calculation of diluted net income (loss) per share for the three months ended December 31, 2020 and 2019, respectively, as such awards were anti-dilutive. Additionally, there were 1,419 and 2,550 stock-based awards excluded for the three months ended December 31, 2020 and 2019, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

There were 709 and 689 restricted stock awards and stock options excluded from the calculation of diluted net income (loss) per share for the six months ended December 31, 2020 and December 31, 2019, respectively, as such awards were anti-dilutive. Additionally, there were 1,429 and 2,745 stock-based awards excluded for the six months ended December 31, 2020 and December 31, 2019, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

Share Repurchase Program

On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the six months ended December 31, 2020, the Company repurchased 2,204 shares under the repurchase program for a total of

$71,693, excluding commissions, at an average price of $32.53 per share. As of December 31, 2020, the Company had $118,136 of remaining authorization under the share repurchase program.